New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
GH Research PLC (GHRS)
GHRS · NGM · Common · CUSIP G3855L106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GHRS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G3855L106
IPO
6/25/2021 · 10 Million Shares @ $16.00/share
Prospectus
IPO prospectus »
Business: GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Company Contact

CEO
Theis Terwey
VPF
Julie Ryan
Investor Relations
investors@ghres.com
SEC EDGAR Filings
View filings »